These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9104904)

  • 21. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.
    Gomes JA; Ip J; Santoni-Rugiu F; Mehta D; Ergin A; Lansman S; Pe E; Newhouse TT; Chao S
    J Am Coll Cardiol; 1999 Aug; 34(2):334-9. PubMed ID: 10440141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Marketou ME; Solomou MC; Kanoupakis EM; Vardas PE
    Am J Cardiol; 1998 Apr; 81(8):995-8. PubMed ID: 9576159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M; Cullen MT; Casadei G
    Am J Cardiol; 1996 Jan; 77(3):60A-75A. PubMed ID: 8607393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
    Meinertz T; Lip GY; Lombardi F; Sadowski ZP; Kalsch B; Camez A; Hewkin A; Eberle S;
    Am J Cardiol; 2002 Dec; 90(12):1300-6. PubMed ID: 12480038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial].
    Wang AH; Pu JL; Qi XY; Miao WL; Hou ZS; Cong HL; Zhou JZ; Liu XF; Li SM; Han QH; Liu YJ; Yang XC
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1677-81. PubMed ID: 21914315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ; Anderson JL
    Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Propafenone dose for emergency room conversion of paroxysmal atrial fibrillation].
    Antonelli D; Darawsha A; Rimbrot S; Freedberg NA; Rosenfeld T
    Harefuah; 1999 Jun; 136(11):857-9, 915. PubMed ID: 10955129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
    N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
    Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
    Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias.
    Hsieh MH; Chen SA; Wen ZC; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):37-45. PubMed ID: 9579815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
    Piccini JP; Kong DF
    Europace; 2011 Mar; 13(3):295-6. PubMed ID: 21345924
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation].
    Cointe R; Metge M; Bru P; Vrancea F; Gerard R; Paganelli F; Lévy S
    Ann Cardiol Angeiol (Paris); 1993 Apr; 42(4):223-7. PubMed ID: 8517602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation].
    Zadura M; Grossmann G; Modrzewska A; Klecha T; Klepacka H; Rumiński W
    Pol Merkur Lekarski; 2001 Aug; 11(62):137-9. PubMed ID: 11757212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.